Roche Holding AG (RO)

Currency in CHF
275.80
-1.20(-0.43%)
Delayed Data·
RO Scorecard
Full Analysis
Has raised its dividend for 28 consecutive years
Earnings results expected today
Fair Value
Day's Range
275.40283.80
52 wk Range
244.00333.60
Key Statistics
Bid/Ask
276.40 / 277.00
Prev. Close
277
Open
282
Day's Range
275.4-283.8
52 wk Range
244-333.6
Volume
10.15K
Average Volume (3m)
24.51K
1-Year Change
-6.73%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
360.00
Upside
+30.53%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Roche Holding AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Roche Holding AG Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Employees
103249

Compare RO to Peers and Sector

Metrics to compare
RO
Peers
Sector
Relationship
P/E Ratio
25.6x20.6x−0.5x
PEG Ratio
−0.90−0.040.00
Price/Book
6.7x1.8x2.6x
Price / LTM Sales
3.4x3.1x3.2x
Upside (Analyst Target)
31.3%68.4%41.9%
Fair Value Upside
Unlock10.5%4.3%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 360.00
(+30.53% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 10.39%
Dividend Yield
3.50%
Industry Median 2.33%
Annualised payout
9.70
Paid annually
5-Years Growth
+1.51%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-- / --
Revenue / Forecast
15.44B / 15.30B
EPS Revisions
Last 90 days

RO Income Statement

People Also Watch

93.32
NOVN
+0.21%
615.00
ASML
+1.38%
1,761.500
RHMG
-0.87%
7.666
ENEI
-0.88%

FAQ

What Stock Exchange Does Roche Holding Trade On?

Roche Holding is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for Roche Holding?

The stock symbol for Roche Holding is "RO."

What Is the Roche Holding Market Cap?

As of today, Roche Holding market cap is 219.69B.

What Is Roche Holding's Earnings Per Share (TTM)?

The Roche Holding EPS (TTM) is 10.39.

When Is the Next Roche Holding Earnings Date?

Roche Holding will release its next earnings report on 23 Jul 2025.

From a Technical Analysis Perspective, Is RO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Roche Holding Stock Split?

Roche Holding has split 1 times.

How Many Employees Does Roche Holding Have?

Roche Holding has 103249 employees.

What is the current trading status of Roche Holding (RO)?

As of 24 Jul 2025, Roche Holding (RO) is trading at a price of 275.80, with a previous close of 277.00. The stock has fluctuated within a day range of 275.40 to 283.80, while its 52-week range spans from 244.00 to 333.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.